Company Profile

New Horizon Longevity Technology Co., Limited occupies a high ground in eye health research and clinical practice, laying out technological innovation in the entire diagnosis and treatment chain.The product includes Herbal Brightening and Aging Eye Care Liquid, Macular Eye Care Liquid, Eye Moisturizing Spray, etc. Laohua Eye Protection Liquid, a traditional Chinese medicine product under the name of Materia Medica, is the second monomeric product under modern medical technology after artemisinin; Macular eye care solution can alleviate visual impairment caused by macular degeneration; Moisturizing eye spray can prevent eye diseases and relieve visual fatigue.The drug pipeline has global innovation. The breakthrough drug R&D pipeline includes the herbal Mingmu Laohua Eye Care Liquid 2.0 pipeline, which will benefit patients with diabetes retinopathy or presbyopia, age-related macular degeneration, cataract and glaucoma; The company cooperates with the Hong Kong government and Professor Zhou of the Hong Kong Polytechnic University to develop eye drops and oral supplements to treat diabetes retinopathy and presbyopia; Cooperate with the Hong Kong government and Dean Feng of the School of Traditional Chinese Medicine of the University of Hong Kong to develop drug pipelines for diabetes retinopathy and macular diseases.Introduction to longevity drugs: NAD+products synthesized from traditional Chinese medicine are undergoing clinical research with the School of Chinese Medicine at the University of Hong Kong.Some of the company's pipelines have entered the stage of full industrialization and plan to go public in the United States in 2025. After going public, they will use capital market financing to promote the third phase clinical and industrialization of other pipelines.

Corporate culture

  • Our goals and positioning

    A globally leading integrated industry platform for the development and transformation of ophthalmic drugs and longevity anti-aging products

  • our mission

    Promote human health, longevity, and happiness

  • Our vision

    A promise is worth a thousand ounces of gold, the world's great harmony

  • Our values

    Innovation, Excellence, and Sharing

Our experts

A globally leading integrated industry platform for the research, development, and transformation of ophthalmic drugs and longevity anti-aging products.

Founder of the World Ophthalmology Organization. The technological achievements include over one hundred articles, of which seven were published in the British journal Nature.

Lin Wenjie

Harvard University Professor Chief Scientist
Top 2% of global scientists in the field of ophthalmology by 2024, professor at the School of Ophthalmology and Optometry and the Department of Applied Biotechnology at The Hong Kong Polytechnic University.

Zhou Lei

Professor at Hong Kong Polytechnic University
Top 1% of global scientists in the field of traditional Chinese medicine by 2024. Professor, Doctor of Medicine, and Doctoral Supervisor at the School of Chinese Medicine, University of Hong Kong.

Feng Yibin

Dean of the School of Chinese Medicine, University of Hong Kong

Press Center

Products and Services

New Horizon Longevity Technology Co., Limited occupies a high position in eye health research and clinical practice, with products covering ocular surface and fundus diseases, including Bencao Mingmu 1.0 presbyopia eye care solution, macular eye care solution, eye moisturizing spray, etc.

Hong Kong local production, cross-border supply chain advantages

Online message